Compliance Processes for Life Science Products in Brazil, Russia, India, China markets - Company Establishment, Clinical Trials, Registrations, Renewals and Supply Chain Considerations: 2-day In-person Seminar
Robert J. Russell, President of RJR Consulting, Inc
Thursday, April 9, 2015 | Friday, April 10, 2015
Thursday, July 9, 2015 | Friday, July 10, 2015
This seminar will help you understand the regulatory, quality and import / export requirements for Life Science Products in emerging markets - Brazil, Russia, India and China.
Improved alignment to global standards was an important step forward toward foreign access, because it eliminated the conflicting standards that prevailed among provincial government agencies. Healthcare Authorities and regulatory systems have now made their requirements and procedures more transparent to industry partners. Clinical Trials can be conducted at a fraction of the expense.
Structured healthcare systems and insurance coverage is now more prevalent among these emerging nation populations and predictions for growth of Rx and OTC products is impressive in these relatively untapped markets.
This course specifically focuses on the overall regulatory compliance requirements and procedures for Pharmaceuticals, Medical Devices, Biologics and Combination Products in Brazil, Russia, India and China. The course will cover topics relating to pre-clinical and clinical requirements, as well as, addressing the structure of the regulatory agencies. Content will also include descriptions of the methods by which regulators review filings and registrations and what is expected in the authorization and dossier maintenance of licensed products throughout their life.
Understanding cultural norms, establishing relationships and protecting your intellectual property will also be discussed and these will need to be integrated into your company training and corporate business strategies.
This course is designed to provide a detailed overview of the regulatory requirements, local challenges and important cultural aspects of working with the lifecycle of Life Science Products (pharmaceuticals, medical devices, biologics and combination products) as an importer or producer in these emerging markets. It will provide training on:
Who will Benefit:
This course will be beneficial to the following personnel whose responsibilities require knowledge of these Emerging Markets' regulatory requirements for Life Science products:
Topic Back Ground:
More than ever, the World has become one integrated market for conducting Global Clinical Research and for expanding the market for pharmaceuticals, biologics, medical devices and combination products. The time and expense of bringing new products to market continue to challenge budgets and existing balance sheets. While it is necessary to continue to have a robust pipeline of new patented products, global producers have been evaluating how best to begin participating in the emerging markets of Brazil, Russia, India and China. Manufacturers are looking to tap into the huge population areas of the World and bring innovative products to these patient populations. Taking products which already have existing country licenses and expanding these licenses into BRIC nations is proving to be an effective strategy for those who have begun.
The BRIC nations, as they are known (Brazil, Russia, India and China) have been improving the sophistication of their regulatory regime governing the food and Life Science products industry in recent years. This has included amending GMP ,GLP, GCP, GSP and other regulations allowing their country policies to further align with international standards of practice. This better alignment will assist the growth in these markets for new and already licensed products. For manufacturers and distributors of Life Science Products in these emerging markets, it is important to pay close attention to the pace at which their Healthcare Agencies implement these changes. Manufacturers and distributors must in turn add this knowledge and adjust their standard operating procedures when necessary to ensure compliance with the evolving regimes.
This course will be beneficial to Regulatory, Quality, Clinical, Manufacturing, Supply Chain, Global Business Development and General Management personnel whose responsibilities require knowledge of these Emerging Market’s regulatory, quality and import / export requirements. Additionally, administrative staff responsible for ensuring compliance with regulatory filings and overall GCP, GMP and GLP compliance requirements will also find this training highly relevant. Global business development and general management requiring an understanding of how regulations and compliance issues must be followed in finding a local distributor / partner, setting up a company office or establishing local or contract manufacturing facility will profit from attending.
Meet Your Instructor
Newark, NJ(Venue to be announced shortly)
Atlanta, GA(Venue to be announced shortly)
TestimonialsWhat past attendees say
Presenter was very knowledgeable. A good number of participants were there and it was a highly interactive seminar.
This seminar was very informative especially the topics related to Brazil. Speaker was very knowledgeable on this topic.
It was a great seminar and I found it extremely informative. Interaction among participants was really great.
Seminar was quite interesting especially in terms of good networking and sharing personal experiences.
This seminar was really useful and it did provide some good insight on drugs and biologics compliance process for BRIC.
This seminar was good and it was good to get an understanding of medical device registration because I work in Regulatory Affairs.
It did provide very useful information about Russia and China Life Science products compliance processes.
Presenter was very knowledgeable. Topic Biologics import to these countries were really useful as this is related to my current job profile.
Instructor was really good and he had given good examples related to the subject. Classroom participation was great. Cultural issues discussed were extremely helpful because these are the unwritten rules that have significant impact for product approval.
Centennial Olympic Park
Centennial Olympic Park is a 21 acre public park located in downtown Atlanta, Georgia owned and operated by the Georgia World Congress Center Authority. The park was built by the Atlanta Committee for the Olympic Games (ACOG) as part of the infrastructure improvements for the Centennial 1996 Summer Olympics. The park plays host to millions of visitors a year and several events, including a summer popular music concert series (Wednesday WindDown) and an annual Independence Day concert and fireworks display.
The Georgia Aquarium houses more than 100,000 animals, representing 500 species, all of which reside in 10 million US gallons of marine and fresh water. It was the world's largest aquarium when it opened in 2005. The aquarium's notable specimens include four young whale sharks, four beluga whales, eleven bottlenose dolphins, and four manta rays. It is the only institution outside Asia housing whale sharks, kept in a 6.3-million US gallon tank—the aquarium as a whole was designed around the whale shark exhibit. The facility also features 3D and 4D movies as part of their attractions.
High Museum of Art
The High Museum of Art (colloquially the High), located in Atlanta, is the leading art museum in the Southeastern United States. Located on Peachtree Street in Midtown, the city's arts district, the High is a division of the Woodruff Arts Center. In 2010, the museum recorded a landmark 509,000 visitors. It is also referred to as Louvre Atlanta thanks to its local popularity. The High Museum holds more than 14,000 works of art in its permanent collection. Included in this collection are 19th- and 20th-century American art; European art; decorative arts; and modern and contemporary art and photography. Highlights of the permanent collection include works by Giovanni Battista Tiepolo, Claude Monet, Martin Johnson Heade, Dorothea Lange, Clarence John Laughlin, and Chuck Close.
The zoo is one of four zoos in the U.S. currently housing giant pandas. Zoo Atlanta's Outback Station houses Australian wildlife, including red kangaroos, Major Mitchell's cockatoos and southern cassowary. This part of the zoo is a petting zoo and home to Saanen goats, Oberhasli goats, Southdown babydoll sheep, Gulf Coast sheep, Nigerian dwarf goats and a Kunekune pig. Other popular exhibits include the Ford African Rain Forest, Boundless Budgies: A Parakeet Adventure, Trader's Alley and Complex Carnivores, African Plains, Giant Pandas, Asian Forest and the World of Reptiles.
Fernbank Museum of Natural History
Fernbank Museum of Natural History presents exhibitions and programs about natural history that entertain as well as educate the public. Its mission is to encourage a greater appreciation of the planet and its people. Fernbank Museum has a number of permanent exhibitions and regularly hosts temporary exhibitions in its expansive facility. Giants of the Mesozoic, on display in the atrium of the museum, features a 123-foot (37 m) long Argentinosaurus (the largest dinosaur ever classified) as well as a Giganotosaurus. The permanent exhibition, A Walk Through Time in Georgia, tells the twofold story of Georgia's natural history and the development of the planet. Fernbank Museum has won several national and international awards for its newest permanent exhibition, Fernbank NatureQuest, an immersive, interactive exhibition for children.
Atlanta Botanical Garden
The Atlanta Botanical Garden is a 30-acre botanical garden located adjacent to Piedmont Park in Midtown Atlanta, Georgia. Incorporated in 1976, the garden's mission is to "develop and maintain plant collections for the purposes of display, education, conservation, research and enjoyment." In winter, the garden has a holiday light show featuring displays created with over 1.5 million lights. The Atlanta Botanical Garden is home to the Kendeda Canopy Walk, a 600-foot-long skywalk that allows the visitors to tour one of the city's last remaining urban forests ¬from around 40 feet in the air through the treetops of the Storza Woods. The skywalk extends from a bluff in the garden into the branches of oaks, hickories and poplars. The structure also provides an aerial view of the woodland garden below. In 2006, an exhibition of the sculpture of Niki de Saint Phalle opened to the public. These huge mosaic sculptures came to the garden from France, Germany, and California.
Atlanta Cyclorama and Civil War Museum
The Atlanta Cyclorama and Civil War Museum is a civil war museum in Atlanta, most noted for its attraction the Atlanta Cyclorama, a cylindrical panoramic painting of the Civil War Battle of Atlanta. The museum is located in historic Grant Park, adjacent to Zoo Atlanta. The museum displays a wide range of pictures and artifacts from the Civil War. The Atlanta Cyclorama, currently valued at $25 million, is one of the world’s largest painting that visitors view from the inside, after entering through an entrance in the floor. Once seated, the central cylinder rotates slowly, affording a view of the entire painting.
We need below information to serve you better